Squarepoint Ops LLC trimmed its holdings in BlueLinx Holdings Inc. (NYSE:BXC - Free Report) by 84.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 3,747 shares of the construction company's stock after selling 21,108 shares during the period. Squarepoint Ops LLC's holdings in BlueLinx were worth $383,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP lifted its position in BlueLinx by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 579,636 shares of the construction company's stock valued at $59,216,000 after buying an additional 1,889 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of BlueLinx by 8.4% in the 4th quarter. American Century Companies Inc. now owns 311,567 shares of the construction company's stock worth $31,830,000 after acquiring an additional 24,087 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of BlueLinx by 19.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 199,871 shares of the construction company's stock worth $20,419,000 after acquiring an additional 32,693 shares during the last quarter. Towle & Co. boosted its position in shares of BlueLinx by 7.2% during the 4th quarter. Towle & Co. now owns 120,972 shares of the construction company's stock worth $12,358,000 after purchasing an additional 8,123 shares during the period. Finally, Northern Trust Corp boosted its position in shares of BlueLinx by 12.8% during the 4th quarter. Northern Trust Corp now owns 92,199 shares of the construction company's stock worth $9,419,000 after purchasing an additional 10,438 shares during the period. Hedge funds and other institutional investors own 90.83% of the company's stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on BXC shares. Loop Capital decreased their target price on BlueLinx from $120.00 to $115.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Benchmark dropped their price objective on shares of BlueLinx from $120.00 to $110.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Wall Street Zen raised shares of BlueLinx from a "sell" rating to a "hold" rating in a research note on Friday, May 30th. Finally, DA Davidson reduced their target price on shares of BlueLinx from $119.00 to $80.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, BlueLinx currently has a consensus rating of "Moderate Buy" and a consensus target price of $110.00.
Check Out Our Latest Research Report on BXC
BlueLinx Stock Performance
Shares of NYSE BXC traded up $1.92 during midday trading on Monday, reaching $69.29. 64,946 shares of the company were exchanged, compared to its average volume of 81,047. The stock has a market cap of $555.84 million, a P/E ratio of 11.28 and a beta of 1.91. BlueLinx Holdings Inc. has a 1 year low of $63.14 and a 1 year high of $134.79. The stock has a fifty day simple moving average of $69.58 and a 200 day simple moving average of $89.82. The company has a current ratio of 4.85, a quick ratio of 3.26 and a debt-to-equity ratio of 0.89.
BlueLinx Company Profile
(
Free Report)
BlueLinx Holdings Inc, together with its subsidiaries, engages in the distribution of residential and commercial building products in the United States. It distributes specialty products, including engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products; and structural products, such as lumber, plywood, oriented strand boards, rebars and remesh, as well as other wood products that are used for structural support in construction projects.
Featured Articles

Before you consider BlueLinx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BlueLinx wasn't on the list.
While BlueLinx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.